In this webinar recording, we'll give you an overview of the end-to-end clinical trial process, highlighting common challenges, with tools and techniques to overcome these and reach submission quicker.
At CDISC International Interchange 2014, Formedix CEO Mark Wheeldon delivered this short "CDISC: Standards from the Start" presentation before participating in a panel discussion.
Formedix CEO Mark Wheeldon delivered this in-depth Define-XML presentation at PhUSE 2014 in London. You'll learn about Define-XML's varied uses beyond dataset description.
Mark Wheeldon (Formedix) and Paula McHale (PAREXEL Informatics) discuss available tools and standards to reduce the time and cost of an end-to-end clinical trial, in this webinar recording.
Mark Wheeldon explores the many and varied uses of Define-XML in this presentation from the PharmaSUG Annual Conference 2014 in San Diego.
Based on a recent poll, 71 percent of CDISC users have implemented Define-XML. This white paper explores alternative uses of Define-XML, from study set-up to production of CDISC Study Data.
This infographic illustrates six of the most common challenges that CROs experience in the battle to win sponsor business.
This presentation discusses real life-experiences of using CDISC Database Standards (Operational Data Model) to drive efficiencies in study setup and study build.
This white paper shows, at-a-glance, the new features and improvements in the latest version of this CDISC standard and its day-to-day use.
Formedix CEO Mark Wheeldon's presentation from the 2013 Bay Area User Group, which looks at practical uses of Define-XML in the end-to-end clinical trial process.